NewsBite

Prostate cancer

September

Telix CEO Christian Behrenbruch has upgraded 2024 revenue forecasts.

Telix on $1b spending spree to build US radiopharmacy network

The biotech is investing heavily in global networks that will enable it to control the supply and distribution of nuclear medicines used to treat cancer.

  • Michael Smith

July

Telix CEO Christian Behrenbruch has upgraded 2024 revenue forecasts.

Telix shares hit new high on upgraded revenue forecast

The biotech’s shares double in value this year due to strong sales in the United States for its prostate cancer imaging product.

  • Michael Smith

June

A digital wellness platform has won the best innovation prize in the health industries category.

AI beats the experts at detecting prostate cancer

When international AI teams competed with a pool of 62 radiologists in the first large-scale contest to diagnose prostate cancer, the machine won.

  • Jill Margo

May

An MRI scan. A trial showed that twice as many cases of prostate cancer were picked up by such scans than by the diagnostic blood tests in use at the moment.

The nine things every man needs to know about prostate cancer now

Experts at the cutting edge of new research into the causes and treatments answer the questions you might be afraid to ask.

  • Catalina Stogdon

April

written by Ben Groundwater
iStock image for Traveller. Re-use permitted.

Revolutionary app offers vital prostate cancer info

A new online web app put out by the Prostate Cancer Foundation of Australia aims to help those living, recovering and at risk of the disease.

  • Sophia McCaughan
Advertisement

As prostate cancer surges, Australia breaks new ground

As low and middle-income countries await a surge in prostate cancer, Australia is driving ahead with cutting-edge treatments and new ways of solving old problems.

  • Jill Margo

July 2023

“It has been 15 years in the making, the typical time for translation from bench to bedside, “says professor Brooks.

Aussie team leads ‘life-saving’ prostate cancer breakthrough

Using novel technology, a new test aims to sharpen predictions about the aggressiveness of individual prostate cancers.

  • Jill Margo

June 2023

Maxwell Plus had built an AI-powered business but investors weren’t as interested two years ago.

‘Just missed out’: The AI start-up that went bust before the hype hit

Elliot Smith has watched with dismay as the artificial intelligence hype cycle reaches fever pitch, after his promising cancer screening start-up hit the skids.

  • Jessica Sier

July 2022

Professor Smith says a new study shows survival at each stage of prostate cancer has increased in the last 30 or 40 years, and particularly in men with distant spread.

Why 6000 extra prostate cancers is not really an increase at all

While official figures make it seem like an extra 6000 men will be diagnosed with prostate cancer this year, it is not the case.

  • Jill Margo

May 2022

The impact on fat mass and weight of a malfunctioning MC4R are, the paper notes, detectable as early as five years old.

Spare tyre increases risk death from prostate cancer

Men with a “spare tyre” of excess fat around the waist are at greater risk of dying from prostate cancer, researchers have found for the first time.

  • Laura Donnelly

February 2022

“I have never had to look at a brick wall. I’ve been the beneficiary of progressive medical success and regard myself as very lucky,” says Laurie Cox

One man’s mission to make prostate cancer fix open to all

Although the wealthy can pay for a new life-extending treatment for prostate cancer, funding is needed to make it accessible to all.

  • Jill Margo

November 2021

Dr Christian Behrenbruch CEO, Telix Pharmaceuticals, has gained TGA approval for its lead prostate cancer imaging product.

Telix gets first regulatory tick on prostate cancer imaging product

The Therapeutic Goods Administration has approved the biotech’s product Illuccix, helping to push its shares higher by over 8 per cent.

  • Carrie LaFrenz

October 2021

Between 1994 and 2008, radical prostatectomies in Australia jumped fivefold,

Taking the panic out of prostate cancer

While there is still a way to go, much of the emotive language has gone, the discourse has matured and momentum is building for new screening guidelines.

  • Jill Margo
Jeff Dunn says it is “completely unacceptable” that specialists are seeing significantly higher rates of late diagnosis and death in men over 70.

Prostate cancer screening guidelines ‘putting lives at risk’

Specialists say current guidelines don’t include new technology that can sharpen diagnosis and reduce the fear of overtreatment.

  • Jill Margo

August 2021

Telix boss Dr Christian Behrenbruch.

Telix Pharma is on the cusp of first US FDA approval

The nuclear medicine company is not only going after the huge US market, it has the equivalent documentations with 17 other countries’ regulators.

  • Carrie LaFrenz
Advertisement

January 2021

The strong anti-inflammatory properties of coffee mean it can improve the prognosis for cancer patients, say experts.

Coffee lowers risk of prostate cancer death, says new study

Every cup could reduce the chance by as much as 1 per cent, say researchers at China Medical University.

  • Dominic Penna

October 2020

Are men in the private health system being overtreated for prostate cancer?

Experts baffled by private v public prostate cancer treatments

Men with early prostate cancer have more radical treatment in the private health system, according to a Victorian study, but experts don't know why.

  • Jill Margo

July 2020

In hospital, Tony Webber after his biopsy.

The man who fell through every prostate cancer safety net

Position and education aside, like most Australian men, Tony Webber didn't have a clue that his symptoms might signal prostate cancer and the system didn't help him, writes Jill Margo.

  • Jill Margo

June 2020

"This treatment holds the key to eliminating prostate cancer as a cause of death," says prostate cancer survivor Mike Milken.

What caught Mike Milken's eye in Melbourne

'This work holds the key to eliminating prostate cancer as a cause of death,' says the American philanthropist.

  • Jill Margo

March 2020

If their cancer spread is missed, men might undergo treatment with curative intent only to find out, six or 12 months later, that it failed, says Professor  Hofman

Prostate cancer's new standard of care

Australian researchers have provided the world with what is likely to become a new standard of care for men with prostate cancer.

  • Jill Margo

Original URL: https://www.afr.com/topic/prostate-cancer-1msn